Th2 cell clonal anergy as a consequence of partial activation

doi:10.1084/jem.180.4.1195

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Sloan-Lancaster, J.
	Articles by Allen, P. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Sloan-Lancaster, J.
	Articles by Allen, P. M.


Social Bookmarking

	What's this?

ARTICLES

Th2 cell clonal anergy as a consequence of partial activation

J Sloan-Lancaster, BD Evavold and PM Allen
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.

We have demonstrated Th2 clonal anergy as a consequence of partial T cell activation by immunogenic peptide and chemically fixed APC, as well as by altered peptide ligand and live antigen-presenting cells (APC). Either stimulation resulted in a profound inability of the T cells to proliferate upon restimulation with antigen and functional APC, a similar phenomenon to that found with Th1 cells. The anergic state was long lasting and was restricted to proliferation, since the T cells retained the ability to produce cytokines upon restimulation, albeit at slightly reduced levels. Th2 anergy induction was inhibited by cyclosporine A, but not by provision of exogenous costimulation or growth factors. The data presented unify Th1 and Th2 cells with regard to anergy and suggest that the fundamental control during anergy for both subsets is prevention of clonal expansion, thus blocking amplification of the immune response.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Mostbock, S., Vidal, S., Schlom, J., Sabzevari, H. (2007). Enhanced Levels of Costimulation Lead to Reduced Effector/Memory CD8+ T Cell Functionality. J. Immunol. 179: 3524-3534 [Abstract] [Full Text]
Ito, T., Wang, Y.-H., Duramad, O., Hori, T., Delespesse, G. J., Watanabe, N., Qin, F. X.-F., Yao, Z., Cao, W., Liu, Y.-J. (2005). TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202: 1213-1223 [Abstract] [Full Text]
Margot, C. D., Ford, M. L., Evavold, B. D. (2005). Amelioration of Established Experimental Autoimmune Encephalomyelitis by an MHC Anchor-Substituted Variant of Proteolipid Protein 139-151. J. Immunol. 174: 3352-3358 [Abstract] [Full Text]
Efron, P. A., Martins, A., Minnich, D., Tinsley, K., Ungaro, R., Bahjat, F. R., Hotchkiss, R., Clare-Salzler, M., Moldawer, L. L. (2004). Characterization of the Systemic Loss of Dendritic Cells in Murine Lymph Nodes During Polymicrobial Sepsis. J. Immunol. 173: 3035-3043 [Abstract] [Full Text]
Cho, C. S., Chang, Z., Elkahwaji, J., Scheunemann, T. L., Manthei, E. R., Colburn, M., Knechtle, S. J., Hamawy, M. M. (2003). Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells. Int Immunol 15: 1369-1378 [Abstract] [Full Text]
Ford, M. L., Evavold, B. D. (2003). Regulation of Polyclonal T Cell Responses by an MHC Anchor-Substituted Variant of Myelin Oligodendrocyte Glycoprotein 35-55. J. Immunol. 171: 1247-1254 [Abstract] [Full Text]
Yasutomo, K. (2003). Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus. Rheumatology (Oxford) 42: 214-222 [Abstract] [Full Text]
Snyder, C. M., Zhang, X., Wysocki, L. J. (2002). Negligible Class II MHC Presentation of B Cell Receptor-Derived Peptides by High Density Resting B Cells. J. Immunol. 168: 3865-3873 [Abstract] [Full Text]
Teixeiro, E., Fuentes, P., Galocha, B., Alarcon, B., Bragado, R. (2002). T Cell Receptor-mediated Signal Transduction Controlled by the beta Chain Transmembrane Domain. APOPTOSIS-DEFICIENT CELLS DISPLAY UNBALANCED MITOGEN-ACTIVATED PROTEIN KINASES ACTIVITIES UPON T CELL RECEPTOR ENGAGEMENT. J. Biol. Chem. 277: 3993-4002 [Abstract] [Full Text]
Lipscomb, M. F., Masten, B. J. (2002). Dendritic Cells: Immune Regulators in Health and Disease. Physiol. Rev. 82: 97-130 [Abstract] [Full Text]
Diepolder, H. M., Gruener, N. H., Gerlach, J. T., Jung, M.-C., Wierenga, E. A., Pape, G. R. (2001). Different Levels of T-Cell Receptor Triggering Induce Distinct Functions in Hepatitis B and Hepatitis C Virus-Specific Human CD4+ T-Cell Clones. J. Virol. 75: 7803-7810 [Abstract] [Full Text]
Field, A.-C., Caccavelli, L., Fillion, J., Kuhn, J., Mandet, C., Druet, P., Bellon, B. (2000). Neonatal induction of tolerance to Th2-mediated autoimmunity in rats. Int Immunol 12: 1467-1477 [Abstract] [Full Text]
Kubota, R., Soldan, S. S., Martin, R., Jacobson, S. (2000). An Altered Peptide Ligand Antagonizes Antigen-Specific T Cells of Patients with Human T Lymphotropic Virus Type I-Associated Neurological Disease. J. Immunol. 164: 5192-5198 [Abstract] [Full Text]
Janssen, E. M., van Oosterhout, A. J. M., van Rensen, A. J. M. L., van Eden, W., Nijkamp, F. P., Wauben, M. H. M. (2000). Modulation of Th2 Responses by Peptide Analogues in a Murine Model of Allergic Asthma: Amelioration or Deterioration of the Disease Process Depends on the Th1 or Th2 Skewing Characteristics of the Therapeutic Peptide. J. Immunol. 164: 580-588 [Abstract] [Full Text]
Vidal, K., Daniel, C., Hill, M., Littman, D. R., Allen, P. M. (1999). Differential Requirements for CD4 in TCR-Ligand Interactions. J. Immunol. 163: 4811-4818 [Abstract] [Full Text]
Hernandez, H. J., Stadecker, M. J. (1999). Elucidation and Role of Critical Residues of Immunodominant Peptide Associated with T Cell-Mediated Parasitic Disease. J. Immunol. 163: 3877-3882 [Abstract] [Full Text]
Agranovich, I., Scott, D. E., Terle, D., Lee, K., Golding, B. (1999). Down-Regulation of Th2 Responses by Brucella abortus, a Strong Th1 Stimulus, Correlates with Alterations in the B7.2-CD28 Pathway. Infect. Immun. 67: 4418-4426 [Abstract] [Full Text]
Wei, C.-H., Beeson, C., Masucci, M. G., Levitsky, V. (1999). A Partially Agonistic Peptide Acts as a Selective Inducer of Apoptosis in CD8+ CTLs. J. Immunol. 163: 2601-2609 [Abstract] [Full Text]
Korb, L. C., Mirshahidi, S., Ramyar, K., Sadighi Akha, A. A., Sadegh-Nasseri, S. (1999). Induction of T Cell Anergy by Low Numbers of Agonist Ligands. J. Immunol. 162: 6401-6409 [Abstract] [Full Text]
Millar, A. E., Wleklinski-Lee, M., Kahn, S. J. (1999). The Surface Protein Superfamily of Trypanosoma cruzi Stimulates a Polarized Th1 Response That Becomes Anergic. J. Immunol. 162: 6092-6099 [Abstract] [Full Text]
She, J., Ruzek, M. C., Velupillai, P., de Aos, I., Wang, B., Harn, D. A., Sancho, J., Biron, C. A., Terhorst, C. (1999). Generation of antigen-specific cytotoxic T lymphocytes and regulation of cytokine production takes place in the absence of CD3{zeta}. Int Immunol 11: 845-857 [Abstract] [Full Text]
Gilliland, L. K., Walsh, L. A., Frewin, M. R., Wise, M. P., Tone, M., Hale, G., Kioussis, D., Waldmann, H. (1999). Elimination of the Immunogenicity of Therapeutic Antibodies. J. Immunol. 162: 3663-3671 [Abstract] [Full Text]
Faith, A., Akdis, C. A., Akdis, M., Joss, A., Wymann, D., Blaser, K. (1999). An Altered Peptide Ligand Specifically Inhibits Th2 Cytokine Synthesis by Abrogating TCR Signaling. J. Immunol. 162: 1836-1842 [Abstract] [Full Text]
Kersh, G. J., Donermeyer, D. L., Frederick, K. E., White, J. M., Hsu, B. L., Allen, P. M. (1998). TCR Transgenic Mice in Which Usage of Transgenic {alpha}- and {beta}-Chains Is Highly Dependent on the Level of Selecting Ligand. J. Immunol. 161: 585-593 [Abstract] [Full Text]
Williams, C. B., Vidal, K., Donermeyer, D., Peterson, D. A., White, J. M., Allen, P. M. (1998). In Vivo Expression of a TCR Antagonist: T Cells Escape Central Tolerance But Are Antagonized in the Periphery. J. Immunol. 161: 128-137 [Abstract] [Full Text]
Soares, L. R. B., Orr, P. L., Garovoy, M. R., Benichou, G. (1998). Differential Activation of T Cells by Natural Antigen Peptide Analogues: Influence on Autoimmune and Alloimmune In Vivo T Cell Responses. J. Immunol. 160: 4768-4775 [Abstract] [Full Text]
Rogers, P. R., Grey, H. M., Croft, M. (1998). Modulation of Naive CD4 T Cell Activation with Altered Peptide Ligands: The Nature of the Peptide and Presentation in the Context of Costimulation Are Critical for a Sustained Response. J. Immunol. 160: 3698-3704 [Abstract] [Full Text]
Purbhoo, M. A., Sewell, A. K., Klenerman, P., Goulder, P. J.�R., Hilyard, K. L., Bell, J. I., Jakobsen, B. K., Phillips, R. E. (1998). Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. Proc. Natl. Acad. Sci. USA 95: 4527-4532 [Abstract] [Full Text]
Ryan, K. R., Evavold, B. D. (1998). Persistence of Peptide-induced CD4+ T cell Anergy In Vitro. J. Exp. Med. 187: 89-96 [Abstract] [Full Text]